Results: IXI

Search articles by EPIC code
EPIC IXI
views

IXICO – ahead of expectations, but set not to be so for long...

Medical analytics company IXICO plc (IXI) has announced results for its half-year ended 31st March 2022, including that it now anticipates that it will “materially exceed” market profit expectations for the full year. So what of a current 37.5p share price, down more than 9%?!...

EPIC IXI
views

IXICO – contract award, but how’s the cash burn?...

Biopharmaceutical data analytics company IXICO (IXI) has announced it has been selected for an open-label Phase I/II dose finding study, emphasising it “reflects the confidence of our clients in the use of our services”. So what of a share price slightly ahead to 43.5p, but comparing to 58.5p in December?...

Page 1 of 2 (17 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments